ArticleFrontiers in endocrinology2026
Habitat-radiomics combining multichannel 2.5D deep learning for differentiating adrenal adenomas from metastases using automatic segmentation: a multicenter study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The qualitative diagnosis of lipid-poor adrenal adenomas and metastases presents challenges, yet there is a significant difference in their treatment principles and prognosis. Materials and methods: A total of 390 patients from two hospitals were divided into training, internal validation, and external test sets. Lesion segmentation was performed automatically using the large segmentation model Medical SAM. The 2.5D deep learning model was constructed using the DenseNet-121 architecture. Habitat-radiomics employed the K-means clustering algorithm; both habitat-radiomics and conventional radiomics features were extracted from lesion regions using the PyRadiomics toolkit, with XGBoost machine learning models subsequently developed. The fusion model incorporated the 2.5D deep learning model scores, habitat-radiomics features, and clinical features. Results: The fusion model demonstrated the best overall performance, achieving areas under the ROC curve (AUC) of 0.983, 0.913, and 0.886 in the training, internal validation, and external test sets, respectively. The standalone 2.5D deep learning and habitat-radiomics models also showed good predictive performance, with AUCs ranging from 0.847-0.980, 0.805-0.967, respectively. Conclusion: The fusion model holds potential for noninvasively differentiating lipid-poor adrenal adenomas from metastases and may provide a valuable decision-making basis for subsequent precision treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.